the global hemostasis community came together to exchange scientific knowledge, discuss emerging trends, and explore the future of thrombosis and hemostasis diagnostics. For Werfen, the congress represented an important opportunity to connect with customers, partners, and key opinion leaders from across the EEMEA region and beyond.
A Strong Presence at the Heart of Hemostasis
Werfen welcomed visitors at Booth 909, where they had the opportunity to experience our Complete Hemostasis Solution firsthand. The new ACL TOP Family 70 Series Testing Systems stood at the center of our presence, together with HemoHub, ACL AcuStar, POCT systems, Virtual Reality HemoCell tours, and the comprehensive HemosIL portfolio of reagents.
The booth became a space for meaningful conversations about laboratory efficiency, connectivity, automation, quality, and the evolving needs of modern hemostasis laboratories.
The Value of Scientific Exchange
One of the highlights of Werfen's participation was the sponsored Presentation Theater session, “High-Sensitivity D-Dimer in VTE Exclusion: Clinical Decision Rules and Global Harmonization.” The session featured Dr. Rita Selby and Dr. Tobias Tritschler, who shared valuable perspectives on the evolving role of D-dimer testing in venous thromboembolism exclusion and the importance of harmonization in clinical practice.
Beyond the exhibition area, ISTH offered an exceptional opportunity to follow scientific sessions, review posters, and gather insights on the latest developments in hemostasis. These exchanges are essential to remain close to clinical needs, scientific progress, and the challenges faced by laboratories worldwide.
From Innovation to Customer Conversations
Throughout the congress, the EEMEA Hemostasis team had the chance to engage with customers and partners on topics that are increasingly relevant for the region: workflow optimization, digital solutions, automation, data management, and market positioning. These discussions helped translate innovation into practical value, connecting our portfolio with the real needs of laboratories and healthcare professionals.
The strong interest in integrated solutions confirmed once again how important it is to support laboratories not only with reliable technologies, but also with expertise, collaboration, and a clear understanding of their daily operational challenges.
Stronger Together
ISTH 2026 highlighted a simple but powerful message: scientific progress and innovation become more impactful when they are shared. Each conversation, session, and customer interaction contributed to strengthening our collective knowledge and reinforcing Werfen's role as a trusted partner in hemostasis diagnostics.
By continuing to collaborate across EEMEA and by bringing together science, technology, and customer insight, we can further enhance our impact and help shape the future of hemostasis together.
EEMEA Hemostasis Team




